Raymond J. Furey - 17 Feb 2026 Form 4 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Role: EVP, GC, CCO & Corp Sec
Signature: /s/ Raymond Furey
Issuer symbol: RIGL
Transactions as of: 17 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 19 Feb 2026, 17:06:09 UTC
Previous filing: 12 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Furey Raymond J.	EVP, GC, CCO & Corp Sec	RIGEL PHARMACEUTICALS, INC., 611 GATEWAY BLVD, SUITE 900, SOUTH SAN FRANCISCO	/s/ Raymond Furey	19 Feb 2026	0001577899

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RIGL	Common Stock	Award	$0	+19,497	+60%	$0.000000	51,813	17 Feb 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest quarterly over three (3) years, with the first quarterly vest occurring on March 31, 2026.